[1]
K. Dhanabalan, A. Subramaniam, and S. Ramanathan, “#48 A novel UPLC method development, validation and forced degradation studies on Lamivudine and Dolutegravir in combined pharmaceutical dosage form”, J Pharm Chem, vol. 8, no. Supplement, Jul. 2022, Accessed: Nov. 22, 2024. [Online]. Available: https://pubs.vensel.org/index.php/jphchem/article/view/168